4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0000950170-24-025189
EVP & Chief Commercial Officer sold 26,949 shares at an average $1.18 ($31,684)
From the SEC's structured data for this filing
Trades in this filing
Cheng Sohanya Roshan · EVP & Chief Commercial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-29 | Sale : show line 1 in the form | −21,840 | $1.17 | $25,553 | 398,618 | D |
| 2024-03-01 | Sale : show line 2 in the form | −5,109 | $1.20 | $6,131 | 393,509 | D |
| Open-market sales · 26,949 sh · avg $1.18 · $31,684 | ||||||
Loading xslF345X05/ownership.xml…